NCT06333379 - Aspergillosis Detection Via EBC-GM in Ventilated Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

December 30, 2023

Study Completion Date

January 10, 2024

Conditions

Bronchoalveolar Lavage FluidSensitivity and SpecificityCritical IllnessRespiration FailureRespiratory Fungal InfectionExhaled Breath CondensateAspergillosis, Invasive Pulmonary

Interventions

OTHER

Compare the levels of Galactomannan (GM) levels in exhaled breath condensate (EBC) and BALF

Investigators tested EBC-GM levels and BALF-GM levels in patients with confirmed IPA to compare the diagnostic value of EBC-GM versus BALF-GM.

Trial Locations (1)

86610072

Sichuan Provincial People's Hospital, Chengdu